Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1634-1644

  Wen, Yongjun ^a,b   Wang, Hualei ^a   Wu, Hua ^b   Yang, Fuhe ^b   Tripp, Ralph A ^a   Hogan, Robert J ^a   Fu, Zhen F ^a,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD86 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTRALIZING ANTIBODY; RABIES VACCINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INNATE IMMUNITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; TREATMENT RESPONSE; VIRUS GENOME; VIRUS IMMUNITY; VIRUS RECOMBINANT; VIRUS TITRATION; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CHEMOKINE CCL22; CHEMOKINE CCL3; CHEMOKINES; CRICETINAE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, INNATE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; RABIES; RABIES VACCINES; RABIES VIRUS; RECOMBINATION, GENETIC; VACCINATION;

MUS; RABIES VIRUS;

EID: 78951485599     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01552-10     Document Type: Article

References (59)

1. Banchereau, J., et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
3. Becker, Y. 2003. Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells - a review. Virus Genes 26:119-130. (Pubitemid 36649155)
4. Bekeredjian-Ding, I. B., et al. 2005. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174:4043-4050.
5. Biragyn, A., et al. 2002. DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 100:1153-1159. (Pubitemid 34864265)
6. Blancou, J., et al. 1989. Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat. Ann. Rech. Vet. 20:195-204. (In French.)
7. Brilot, F., T. Strowig, and C. Munz. 2008. NK cell interactions with dendritic cells shape innate and adaptive immunity. Front. Biosci. 13:6443-6454.
8. Brochier, B., et al. 1991. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 354:520-522.
9. Centers for Disease Control and Prevention. 2009. Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania. MMWR Morb. Mortal. Wkly. Rep. 58:3.
10. Chantry, D., et al. 1999. Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3(+), CD4(+), CD8(low) thymocytes. Blood 94:1890-1898. (Pubitemid 29430404)
11. Conzelmann, K. K., J. H. Cox, L. G. Schneider, and H. J. Thiel. 1990. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175:485-499.
12. Crick, J. 1973. The vaccination of man and other animals against rabies. Postgrad. Med. J. 49:551-564.
13. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529-1531.
14. Dieu, M. C., et al. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.
15. Disis, M. L., et al. 1996. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88:202-210. (Pubitemid 26230688)
16. Dominguez, P. M., and C. Ardavin. 2010. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234:90-104.
17. Faber, M., et al. 2005. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J. Virol. 79:15405-15416.
18. Faber, M., et al. 2007. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. J. Virol. 81:7041-7047. (Pubitemid 46986640)
19. Faber, M., et al. 2009. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc. Natl. Acad. Sci. U. S. A. 106:11300-11305.
20. Flamand, A., P. Coulon, F. Lafay, and C. Tuffereau. 1993. Avirulent mutants of rabies virus and their use as live vaccine. Trends Microbiol. 1:317-320.
21. Frazatti-Gallina, N. M., et al. 2004. Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23:511-517.
22. Fu, Z. F. 1997. Rabies and rabies research: past, present and future. Vaccine 15(Suppl.):S20-S24.
23. Gilboa, E. 2007. DC-based cancer vaccines. J. Clin. Invest. 117:1195-1203.
24. Godiska, R., et al. 1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1595-1604.
25. Haddad, D., et al. 2000. Plasmid vaccine expressing granulocyte- macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J. Immunol. 165:3772-3781.
26. Hamilton, J. A., and G. P. Anderson. 2004. GM-CSF biology. Growth Factors 22:225-231.
27. Hanlon, C. A., et al. 1998. First North American field release of a vacciniarabies glycoprotein recombinant virus. J. Wildl. Dis. 34:228-239.
28. Hanlon, C. A., M. Niezgoda, P. Morrill, and C. E. Rupprecht. 2002. Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons. J. Wildl. Dis. 38:420-427.
29. Iellem, A., et al. 2001. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194:847-853.
30. Imai, T., et al. 1999. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:81-88.
31. Inaba, K., et al. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
32. Inoue, K., et al. 2003. An improved method for recovering rabies virus from cloned cDNA. J. Virol. Methods 107:229-236.
33. Jackson, A. C. 2002. Rabies pathogenesis. J. Neurovirol. 8:267-269.
34. Jelley-Gibbs, D. M., T. M. Strutt, K. K. McKinstry, and S. L. Swain. 2008. Influencing the fates of CD4 T cells on the path to memory: lessons from influenza. Immunol. Cell Biol. 86:343-352.
35. Kuang, Y., S. N. Lackay, L. Zhao, and Z. F. Fu. 2009. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res. 144:18-26.
36. Li, J., J. P. McGettigan, M. Faber, M. J. Schnell, and B. Dietzschold. 2008. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine 26:419-426.
37. Lutz, M. B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
38. Martinez, L. 2000. Global infectious disease surveillance. Int. J. Infect. Dis. 4:222-228.
39. Martin-Fontecha, A., A. Lanzavecchia, and F. Sallusto. 2009. Dendritic cell migration to peripheral lymph nodes. Handb. Exp. Pharmacol. 2009:31-49.
40. Meltzer, M. I. 1996. Assessing the costs and benefits of an oral vaccine for raccoon rabies: a possible model. Emerg. Infect. Dis. 2:343-349.
41. Metcalf, D. 2008. Hematopoietic cytokines. Blood 111:485-491.
42. Morrissey, P. J., L. Bressler, L. S. Park, A. Alpert, and S. Gillis. 1987. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139:1113-1119.
43. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27:493-497.
44. Rupprecht, C. E., et al. 2001. Human infection due to recombinant vacciniarabies glycoprotein virus. N. Engl. J. Med. 345:582-586.
45. Rupprecht, C. E., et al. 2010. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm. Rep. 59:1-9.
46. Rupprecht, C. E., J. S. Smith, M. Fekadu, and J. E. Childs. 1995. The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg. Infect. Dis. 1:107-114.
47. Schaniel, C., et al. 1998. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 188:451-463.
48. Schnell, M. J., T. Mebatsion, and K. K. Conzelmann. 1994. Infectious rabies viruses from cloned cDNA. EMBO J. 13:4195-4203.
49. Shi, Y., et al. 2006. Granulocyte-macrophage colony-stimulating factor (GMCSF) and T-cell responses: what we do and don't know. Cell Res. 16:126-133.
50. Shim, E., K. Hampson, S. Cleaveland, and A. P. Galvani. 2009. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine 27:7167-7172.
51. Smith, J. S., P. A. Yager, and G. M. Baer. 1996. A rapid fluorescence focus inhibition test (RFFIT) for determining rabies virus-neutralising antibody, p. 181-192. In F.-X. Meslin, M. M. Kaplan, and H. Koprowski (ed.), Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, Switzerland.
52. Takayama-Ito, M., et al. 2006. A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein. Virus Res. 119:208-215.
53. Tarr, P. E. 1996. Granulocyte-macrophage colony-stimulating factor and the immune system. Med. Oncol. 13:133-140.
54. Wu, M., H. Fang, and S. T. Hwang. 2001. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J. Immunol. 167: 4791-4795.
55. Wunner, W. 1991. The chemical composition and molecular structure of rabies viruses, p. 31-67. In G. M. Baer (ed.), Natural history of rabies, 2nd ed. CRC Press, Inc., Boca Raton, FL.
56. Yi, H., L. Zhang, Y. Zhen, X. He, and Y. Zhao. 2007. Dendritic cells induced in the presence of GM-CSF and IL-5. Cytokine 37:35-43.
57. Yoshie, O., T. Imai, and H. Nomiyama. 2001. Chemokines in immunity. Adv. Immunol. 78:57-110.
58. Zhao, L., H. Toriumi, Y. Kuang, H. Chen, and Z. F. Fu. 2009. The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J. Virol. 83:11808-11818.
59. Zhao, L., et al. 2010. Expression of MIP-1α (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells. J. Virol. 84:9642-9648.